Navigation Links
FDA Approves Contraceptive Ring

The U.S. Food and Drug Administration has approved the first hormone-releasing contraceptive implant. NuvaRing, sold by Organon, Inc., effectively blocks conception between 98 percent and 99 percent of the time -- meaning that for every 100 women who use it for a year, only one or two will become pregnant, the FDA says. That rate is similar to both the birth control pill and the yet-unapproved contraceptive patch, which releases a steady stream of estrogen and progestin that offers a week of pregnancy protection. //

The new prescription device is a circle of soft, flexible polymer measuring 2.1 inches across. It releases a steady stream of the hormones etonogestrel and ethinyl estradiol, molecules like those found in oral contraceptives.


Page: 1

Related medicine news :

1. FDA Approves New HIV Drug, Viread
2. FDA Approves Birth Control Skin Patch
3. FDA Approves New Arthritis Drug, Bextra
4. FDA Approves Elidel Cream for Eczema
5. FDA Approves New Anti-Clotting Drug
6. FDA Approves New surgery Treatment for Farsightedness
7. FDA Approves Anti-Cancer Cell Drug - Zevalin
8. FDA Approves Remodulin for Pulmonary Hypertension
9. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
10. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
11. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
Post Your Comments:

(Date:11/30/2015)... ... 30, 2015 , ... Holcomb – Kreithen Plastic Surgery ... practices in Florida, is proud to announce that Dr. Joshua Kreithen, one of ... Inc., a Johnson & Johnson Company. , Ethicon is a global medical device ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” ... three innovative value-based care arrangements: Essentia Health and UCare, MissionPoint Health Partners, ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... , ... The successful filing of an Investigational New Drug application (IND) is ... this key industry segment, Regis Technologies has decided to sponsor and participate in an ... EST. , Federal law does not allow new drugs to cross state lines until ...
(Date:11/30/2015)... ... 2015 , ... Vasont Systems, a top component content management ... unites with Syncro Soft’s latest software update, oXygen XML editor Version 17.1. Users ... latest release of oXygen® XML editor and the Vasont® CCMS. , The ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015   VolitionRx Limited (NYSE MKT: ... tests for a broad range of cancer types and other ... Micro Conference, which will be held December 1 - 3 in ... VolitionRx will be David Kratochvil , Chief Financial Officer ... Investor Relations. ® blood-based tests for colorectal ...
(Date:11/30/2015)... Nov. 30, 2015  Precision Image Analysis Inc. ... pleased to announce a dramatic expansion of its ... Building on its ISO-9001:2008 certification for its Quality ... Core Lab protocols and procedures. This expansion enables ... activities.  Their Core Lab services include design and ...
(Date:11/30/2015)... BOSTON , November 30, 2015 ... medicines directed at up to 10 G protein-coupled receptor ... PFE ) to research and develop potential new medicines ... targets across multiple therapeutic areas. --> Heptares ... development company and wholly-owned subsidiary of Sosei Group Corporation ...
Breaking Medicine Technology: